AstraZeneca's antibody therapy prevents COVID-19
- 3 years ago
AstraZeneca's new antibody therapy reduced the risk of people developing COVID-19 symptoms by 77% in a late-stage trial, putting the drugmaker on track to offer protection to those who respond poorly to vaccines
#News #Reuters #AstraZeneca #AntibodyTherapy #Vaccines #COVID
#News #Reuters #AstraZeneca #AntibodyTherapy #Vaccines #COVID